Literature DB >> 17942534

WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection.

R Alvarez1, J Reading, D F L King, M Hayes, P Easterbrook, F Farzaneh, S Ressler, F Yang, D Rowley, A Vyakarnam.   

Abstract

Understanding why human immunodeficiency virus (HIV) preferentially infects some CD4(+) CD45RO(+) memory T cells has implications for antiviral immunity and pathogenesis. We report that differential expression of a novel secreted factor, ps20, previously implicated in tissue remodeling, may underlie why some CD4 T cells are preferentially targeted. We show that (i) there is a significant positive correlation between endogenous ps20 mRNA in diverse CD4 T-cell populations and in vitro infection, (ii) a ps20(+) permissive cell can be made less permissive by antibody blockade- or small-interference RNA-mediated knockdown of endogenous ps20, and (iii) conversely, a ps20(low) cell can be more permissive by adding ps20 exogenously or engineering stable ps20 expression by retroviral transduction. ps20 expression is normally detectable in CD4 T cells after in vitro activation and interleukin-2 expansion, and such oligoclonal populations comprise ps20(positive) and ps20(low/negative) isogenic clones at an early differentiation stage (CD45RO(+)/CD25(+)/CD28(+)/CD57(-)). This pattern is altered in chronic HIV infection, where ex vivo CD4(+) CD45RO(+) T cells express elevated ps20. ps20 promoted HIV entry via fusion and augmented CD54 integrin expression; both of these effects were reversed by anti-ps20 antibody. We therefore propose ps20 to be a novel signature of HIV-permissive CD4 T cells that promotes infection in an autocrine and paracrine manner and that HIV has coopted a fundamental role of ps20 in promoting cell adhesion for its benefit. Disrupting the ps20 pathway may therefore provide a novel anti-HIV strategy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942534      PMCID: PMC2224370          DOI: 10.1128/JVI.00939-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The whey acidic protein family: a new signature motif and three-dimensional structure by comparative modeling.

Authors:  S Ranganathan; K J Simpson; D C Shaw; K R Nicholas
Journal:  J Mol Graph Model       Date:  1999-04       Impact factor: 2.518

Review 2.  Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.

Authors:  Stergios Doumas; Alexandros Kolokotronis; Panagiotis Stefanopoulos
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Initial sequence of the chimpanzee genome and comparison with the human genome.

Authors: 
Journal:  Nature       Date:  2005-09-01       Impact factor: 49.962

4.  R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells.

Authors:  Claudia Cicala; James Arthos; Elena Martinelli; Nina Censoplano; Catherine C Cruz; Eva Chung; Sara M Selig; Donald Van Ryk; Jun Yang; Shyla Jagannatha; Tae Wook Chun; Ping Ren; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

5.  CD7 expression distinguishes subsets of CD4(+) T cells with distinct functional properties and ability to support replication of HIV-1.

Authors:  D L Wallace; P M Matear; D C Davies; R Hicks; C Lebosse; J Eyeson; P C Beverley; A Vyakarnam
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

Review 6.  HIV accomplices and adversaries in macrophage infection.

Authors:  Sharon M Wahl; Teresa Greenwell-Wild; Nancy Vázquez
Journal:  J Leukoc Biol       Date:  2006-08-14       Impact factor: 4.962

7.  The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers.

Authors:  M Larsen; S J Ressler; M J Gerdes; B Lu; M Byron; J B Lawrence; D R Rowley
Journal:  Mamm Genome       Date:  2000-09       Impact factor: 2.957

8.  Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.

Authors:  G S Ashcroft; K Lei; W Jin; G Longenecker; A B Kulkarni; T Greenwell-Wild; H Hale-Donze; G McGrady; X Y Song; S M Wahl
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

9.  LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1.

Authors:  Mélanie R Tardif; Michel J Tremblay
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

10.  Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses.

Authors:  Yoshiaki Nishimura; Tatsuhiko Igarashi; Olivia K Donau; Alicia Buckler-White; Charles Buckler; Bernard A P Lafont; Robert M Goeken; Simoy Goldstein; Vanessa M Hirsch; Malcolm A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

View more
  12 in total

1.  Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells.

Authors:  Anna G Drannik; Kakon Nag; Xiao-Dan Yao; Bethany M Henrick; Sumiti Jain; T Blake Ball; Francis A Plummer; Charles Wachihi; Joshua Kimani; Kenneth L Rosenthal
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

2.  Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection.

Authors:  Georgina Thorborn; Laura Pomeroy; Heidi Isohanni; Melissa Perry; Barry Peters; Annapurna Vyakarnam
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

Review 3.  Innate immunity against HIV: a priority target for HIV prevention research.

Authors:  Persephone Borrow; Robin J Shattock; Annapurna Vyakarnam
Journal:  Retrovirology       Date:  2010-10-11       Impact factor: 4.602

Review 4.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

5.  Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis.

Authors:  F B S Briggs; P P Ramsay; E Madden; J M Norris; V M Holers; T R Mikuls; T Sokka; M F Seldin; P K Gregersen; L A Criswell; L F Barcellos
Journal:  Genes Immun       Date:  2010-01-21       Impact factor: 2.676

6.  WFDC1 is a key modulator of inflammatory and wound repair responses.

Authors:  Steven J Ressler; Truong D Dang; Samuel M Wu; Dennis Y Tse; Brian E Gilbert; Annapurna Vyakarnam; Feng Yang; Isaiah G Schauer; David A Barron; David R Rowley
Journal:  Am J Pathol       Date:  2014-09-16       Impact factor: 4.307

7.  Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:C.

Authors:  Anna G Drannik; Kakon Nag; Xiao-Dan Yao; Bethany M Henrick; Jean-Michel Sallenave; Kenneth L Rosenthal
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

8.  WFDC1 expression identifies memory CD4 T-lymphocytes rendered vulnerable to cell-cell HIV-1 transfer by promoting intercellular adhesive junctions.

Authors:  Raymond A Alvarez; Georgina Thorborn; James L Reading; Shalini Kamu Reddy; Annapurna Vyakarnam
Journal:  Retrovirology       Date:  2011-05-05       Impact factor: 4.602

9.  Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking.

Authors:  Oliver J Hickman; Prokar Dasgupta; Christine Galustian; Richard A Smith; Annapurna Vyakarnam
Journal:  Biochem Biophys Rep       Date:  2016-06-15

10.  Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2.

Authors:  Oliver J Hickman; Richard A Smith; Prokar Dasgupta; Sudha Narayana Rao; Soumya Nayak; Shubha Sreenivasan; Annapurna Vyakarnam; Christine Galustian
Journal:  Br J Cancer       Date:  2016-04-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.